|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 USD | -10.78% |
|
-21.99% | +10.37% |
| 15/01 | Ocugen, Inc. - Special Call | |
| 15/01 | Ocugen Says Gene Therapy Reduced Lesion Growth by 46% in Eye Disease Trial | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCUGEN, INC. | Other Biotechnology & Medical Research | -10.78% | -21.99% | +10.37% | +109.86% | -33.18% | 52Cr |  | | |
- Stock Market
- Equities
- OCGN Stock
- Charts Ocugen, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition